Physician profile
Tima T Le
NPI 1952532715
$3,118.76
in general payments reported to CMS, 2019-2025
12 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $436 · 2021: $1,934 · 2022: $13.14 · 2023: $123 · 2024: $94.86 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,529.17 | 2019-2025 | Prodigy, Proclaim |
| Relievant Medsystems, INC. | $112.66 | 2021 | |
| Medtronic, INC. | $99.70 | 2022-2023 | Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $65.19 | 2019-2025 | Intracept |
| Nalu Medical, INC. | $63.21 | 2025 | Nalu Neurostimulation System |
| Scilex Pharmaceuticals INC. | $55.95 | 2019-2024 | Ztlido |
| Arbor Pharmaceuticals, INC. | $54.45 | 2019-2020 | |
| Medtronic USA, INC. | $42.81 | 2019 | |
| Assertio Therapeutics, INC. | $37.87 | 2019 | |
| Averitas Pharma INC. | $25.61 | 2025 | Qutenza |
| Otto Bock Healthcare LP | $18.71 | 2020 | |
| Team_makena_llc | $13.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tima Le listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.